At a glance

ClinicalIndex Comparison Record

N/ACompleted· 24 enrolled

Drug / intervention

Dressing +1 moreother

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03216824

NCT03216824N/ACompleted

Compare CT.gov

CVAD-Associated Skin Impairment: A Pilot Study Comparing Dressing to No-Dressing in Adult Allogeneic Stem Cell Transplant Recipients

University of British Columbia·interventional·Posted Jul 13, 2017·Updated Oct 14, 2019

In Brief

A clinical study evaluating Dressing and No-Dressing for Central Line Complication. Completed, enrolled 24 participants across 1 site.

Detailed Summary

Central venous access device (CVAD)-associated skin impairment (CASI) is a common problem in allogeneic hematopoietic stem cell transplant (HSCT) recipients. In this prospective randomized pilot study, dressing the CVAD exit site will be compared to no-dressing with respect to CASI and CVAD-related bloodstream infection (CRBSI) rates in adult outpatient HSCT recipients. The purpose of this study is to gain information that can be used to design a large randomized controlled trial (RCT).

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsCentral Line Complication

CountriesCanada

Collaborators--

Timeline

N/ACompletedFinished

201820192020202120222023202420252026

First PostedJul 2017

Enrollment StartSep 2017

Primary CompletionNov 2018

TodayJul 2026

First PostedJul 13, 2017

Enrollment StartSep 14, 2017

Primary CompletionNov 4, 2018

TodayJul 2, 2026

Enrollment to primary: 1.1 yearsPosted 9.0 years ago

Interventions

Dressingother

A dressing is maintained on the CVAD exit site.

No-Dressingother

The CVAD exit site is not covered with a dressing.